Changing Of The Guard At US FDA Continues With Unger Retirement

 
• By Michael McCaughan
  
FDA building
The next director of the FDA's Office of Cardiology, Hematology, Endocrinology and Nephrology following Ellis Unger's retirement remains unclear.

More from US FDA

More from Agency Leadership